Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medpace Holdings Inc (NQ: MEDP )

382.71 +25.41 (+7.11%)
Streaming Delayed Price Updated: 3:08 PM EDT, Jul 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings Inc

< Previous 1 2 3 4 5 6 7 Next >
Mid-Day Market Update: Crude Oil Down 4%; US Producer Prices Rise 1% In January
US stocks remained higher midway through trading on Tuesday after Russia announced it would pull back some troops positioned on the Ukrainian border. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-... 
Via Benzinga
Medpace Reports Mixed Q4 Earnings, Issues FY22 Guidance Ahead Of Estimates
Medpace Holdings Inc's (NASDAQ: MEDP)  
Via Benzinga
31 Stocks Moving In Tuesday's Mid-Day Session
Gainers Resonant Inc. (NASDAQ: RESN) jumped 249% to $4.29 after Murata Electronics announced plans to buy the company at $4.50 per share in cash. Tower Semiconductor Ltd. (NASDAQ... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher On Easing Russia-Ukraine Tensions
US stocks opened on a strong note this morning after Russia announced it would pull back some troops positioned on the Ukrainian border. 
Via Benzinga
Recap: Medpace Hldgs Q4 Earnings
Medpace Hldgs (NASDAQ:MEDP) reported its Q4 earnings results on Monday, February 14, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Results
From Medpace Holdings, Inc.
Via Business Wire
Earnings Scheduled For February 14, 2022
Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million. 
Via Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
Earnings Preview For Medpace Hldgs
Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2022-02-14. Here's what investors need to know before the announcement. Analysts estimate that Medpace Hldgs... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 14, 2022
From Medpace Holdings, Inc.
Via Business Wire
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
This Diversified Healthcare Stock Offers Explosive Biotech-Like Growth
Since its IPO five years ago, this clinical trial specialist is up over 700%. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
PerkinElmer Stock, Already Highly Rated, Perks Up Further Amid Brisk Sales, Profit Growth For Its Instruments
A Relative Strength Rating upgrade for PerkinElmer shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Exposures COVID-19
Thermo Fisher Stock Strength Rating Climbs To 81; Medical Devices Maker Shows Market Leadership
Thermo Fisher Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81. 
Via Investor's Business Daily
Medpace Holdings, Inc. Common Stock (MEDP) Q3 2021 Earnings Call Transcript
MEDP earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 135.6 million,... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the... 
Via Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Wallbox N.V. (NYSE: WBX) shares climbed 54.5% to $17.16. Uber and Wallbox N.V. disclosed a strategic partnership to simplify the transition to EVs for Bay Area ride... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Medpace Hldgs (NASDAQ:MEDP) shar... 
Via Benzinga
Medpace Holdings, Inc. Reports Third Quarter 2021 Results
From Medpace Holdings, Inc.
Via Business Wire
Earnings Outlook For Medpace Hldgs
Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2021-10-25. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Medpace Hldgs Insider Trades $12 Million In Company Stock
Susan E Burwig, Exec. Vp And Operations at Medpace Hldgs (NASDAQ:MEDP), made a large insider sell on September 3, according to a new SEC filing. What Happened: A Form 4 filing... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Medpace Holdings, Inc. to Report Third Quarter 2021 Financial Results on October 25, 2021
From Medpace Holdings, Inc.
Via Business Wire
Earnings Scheduled For October 25, 2021
Companies Reporting Before The Bell • HNI (NYSE:HNI) is expected to report quarterly earnings at $0.43 per share on revenue of $592.14 million. • Travelzoo (... 
Via Benzinga
Medpace Stock Earns Relative Strength Rating Upgrade; Remains In Buy Zone
Ohio-based Medpace stock saw its Relative Strength Rating enter the 80-plus level while it stays in a buy zone. 
Via Investor's Business Daily
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
Medpace Holdings, Inc. to Present at Baird’s Global Healthcare Conference
From Medpace Holdings, Inc.
Via Business Wire
A Look Into Medpace's Price Over Earnings
In the current market session, Medpace Hldgs Inc. (NASDAQ:MEDP) is trading at $179.28, after a 0.76% drop. However, over the past month, the stock increased by 2.01... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.